These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11920484)

  • 1. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues.
    Nguyen NP; Sallah S; Karlsson U; Antoine JE
    Cancer; 2002 Feb; 94(4):1131-41. PubMed ID: 11920484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysphagia following chemoradiation for locally advanced head and neck cancer.
    Nguyen NP; Moltz CC; Frank C; Vos P; Smith HJ; Karlsson U; Dutta S; Midyett FA; Barloon J; Sallah S
    Ann Oncol; 2004 Mar; 15(3):383-8. PubMed ID: 14998839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysphagia severity following chemoradiation and postoperative radiation for head and neck cancer.
    Nguyen NP; Moltz CC; Frank C; Karlsson U; Nguyen PD; Vos P; Smith HJ; Dutta S; Nguyen LM; Lemanski C; Chan W; Sallah S
    Eur J Radiol; 2006 Sep; 59(3):453-9. PubMed ID: 16687229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature.
    Rieger JM; Zalmanowitz JG; Wolfaardt JF
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):581-7. PubMed ID: 16697144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality of life for patients treated for head and neck carcinoma].
    Maingon P; Créhange G; Bonnetain F; Ligey-Bartolomeu A; Chamois J; Bruchon Y; Romanet P; Truc G
    Cancer Radiother; 2010 Oct; 14(6-7):526-9. PubMed ID: 20724192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States.
    Wong SJ; Harari PM; Garden AS; Schwartz M; Bellm L; Chen A; Curran WJ; Murphy BA; Ang KK
    Cancer; 2011 Apr; 117(8):1679-86. PubMed ID: 21472715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited mouth opening after primary therapy of head and neck cancer.
    Weber C; Dommerich S; Pau HW; Kramp B
    Oral Maxillofac Surg; 2010 Sep; 14(3):169-73. PubMed ID: 20358238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
    Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M; Haas ML; Van Echo DA; Haddad R; Jacobs MC; Levy S; Gray WC; Ord RA; Conley BA
    Cancer; 2001 Feb; 91(3):548-54. PubMed ID: 11169937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma.
    Tanvetyanon T; Choudhury AM
    Cancer; 2006 Apr; 106(7):1554-9. PubMed ID: 16518817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
    Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI.
    Rinkel RN; Verdonck-de Leeuw IM; Doornaert P; Buter J; de Bree R; Langendijk JA; Aaronson NK; Leemans CR
    Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1849-55. PubMed ID: 26071622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life following chemoradiation and postoperative radiation for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Karlsson U; Nguyen P; Dutta S; Lemanski C; Ludin A; Rose S; Nguyen LM; Ward H; Huang S; Sallah S
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(5):271-6. PubMed ID: 17565229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation.
    Braaksma M; Levendag P
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):63-70. PubMed ID: 12577248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical and psychosocial correlates of head and neck cancer: a review of the literature.
    De Boer MF; McCormick LK; Pruyn JF; Ryckman RM; van den Borne BW
    Otolaryngol Head Neck Surg; 1999 Mar; 120(3):427-36. PubMed ID: 10064650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.